Ethical use of long-acting medications in the treatment of severe and persistent mental illnesses☆
To access this article, please choose from the options below
☆ Supported by National Institute of Mental Health (K02MH01918-03) and National Institute on Drug Abuse (R01DA13139-03) grants to L.W.R.
PII: S0010-440X(04)00018-5
doi:10.1016/j.comppsych.2004.02.003
© 2004 Elsevier Inc. All rights reserved.
